Mazelsky Jonathan Jay reported grant involving 3,323.4332 derivative units of DENTSPLY SIRONA Inc. at $9.03 for $30.0k on Sep 30, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Oct 2, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$30,010.60Shares × reported price
Shares traded
3,323.4332Phantom Stock (Directors' Deferred Compensation) DDC
Price per share
$9.03Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
23,345.1175Direct
Trade date
Sep 30, 2026Grant
Filed
Oct 2, 2026, 4:07 PM ET2-day reporting delay
Accession
0000818479-26-000271Code A · Transaction 234365
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

XRAY price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
XRAY · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +29%1w ago +13%1d ago +3.6%
Returns since7d +1.8%30d +9.8%90d180d1y

Footnotes in full

F1: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock following the reporting person's termination of service as a director. F2: Comprised of phantom stock.